Cite
MLA Citation
Panayiotis Panayiotidis et al.. “A phase-II study of atezolizumab in combination with obinutuzumab or rituximab for relapsed or refractory mantle cell or marginal zone lymphoma or Waldenström's macroglobulinemia.” Leukemia & lymphoma, vol. 63, no. 5, 2022, pp. 1058–1069. http://access.bl.uk/ark:/81055/vdc_100155161372.0x00003a